Medical/Healthcare News

Vittoria Biotherapeutics Wins FDA Clearance for VIPER-101 in T-Cell Lymphoma, Paving the Way for Innovative CAR-T Therapy

PHILADELPHIA, PA — Vittoria Biotherapeutics has hit a significant milestone with the U.S. Food and Drug Administration (FDA) clearing its Investigational New Drug (IND) application for VIPER-101, the company’s leading …

Vittoria Biotherapeutics Wins FDA Clearance for VIPER-101 in T-Cell Lymphoma, Paving the Way for Innovative CAR-T Therapy Read More